Healthcare -
Biotechnology - NASDAQ - FR
$ 1.83
4.57 %
$ 153 M
Market Cap
-4.16
P/E
IPHA - COST OF REVENUE
Cost of Revenue IPHA - Innate Pharma S.A.
56 M
LAST VALUE
9.17%
2 YEAR CAGR
-4.24%
5 YEAR CAGR
22.14%
10 YEAR CAGR